CM Conversations

In this episode, Libby speaks with Bill Buschle, Global Director - Coatings, Adhesives, Speciality Chemicals and Elastomers (CASE), at Alchemy Cloud.Dive into the future of chemical research and development with Libby and Bill. In this insightful podcast, they unravel the challenges faced by R&D teams, emphasising the critical role of process-focused KPIs over binary output metrics. Explore the impact of legacy software and data silos on innovation, and discover how digital integration and AI tools are reshaping the landscape of chemical R&D. The duo share survey insights, shedding light on industry trends and the exciting role of AI in product development. Join the conversation on overcoming challenges in adopting AI and witness the transformation of R&D into a powerhouse of innovation. Stay tuned for success stories and a deep dive into the evolving role of technology in the ever-changing world of chemicals and advanced materials.To learn more about this topic and the chemicals market at Charlton Morris, drop Libby a message on LinkedIn, here or email at libby.sharpe@charltonmorris.com. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Emily speaks with Elan Sudberg, CEO of Alkemist Labs and Chair of the American Herbal Products Association's Psychedelic Plants and Fungi Committee.The committee was chartered in 2022 to address issues related to the safe use and responsible commerce of lawfully marketed products derived from psychedelic plants and fungi. Elan Sudberg was appointed as the committee's first chair. Already CEO of a committed testing laboratory specialising in plant authentication, botanical ingredient identification and quantitative analytical services to the food and beverage, nutraceutical and cosmeceutical industries, he was a perfect fit. His passion for supporting the roll-out of produce with powerful natural benefits to the masses really comes across in this chat, and in the work he is doing across both roles.He discusses industry trends, recent acquisitions and their impact on the market, and the tricky business of navigating FDA regulations in this fascinating space. There's plenty to glean from this fascinating discussion, with a really interesting window into the future of the nutraceuticals industry.To learn more about this topic and the wider nutraceuticals market at Charlton Morris, drop Emily a message on LinkedIn, here, or email at emily.austin@charltonmorris.com. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Indre speaks with Carmen Uphoff, COO of Respeggt, a Dutch-German company aiming to bring positive change to the poultry industry by eliminating chick culling.During the conversation, Carmen delves into the technology that allows for gender identification in the hatching egg; preventing the culling of undesired male chicks, a practice that results in the death of about 6 billion chicks worldwide each year.They also touch on the regulatory landscape, noting how Germany and France have already put legislation in place to prevent chick culling, while others are waiting for EU-wide regulations to change, the future of the poultry sector, including the challenges posed by bird flu and the economic crisis. As well as Carmen's insight into a trend leaning towards smaller, more manageable poultry farms as a risk management strategy.For more insights on animal health and welfare, reach out to Indre on LinkedIn or at indre.semeskeviciute@charltonmorris.com. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Jack speaks with Jacob Glanville and Stephanie Wisner, Co-Founders at Centivax.With a mission to accelerate the world's transition to post-pathogen humanity, its first broad-spectrum vaccine is currently in pre-clinical development in ferrets and pigs for the prevention of all influenza, awarded the 'Gates Foundation Grand Challenge: End the Pandemic Threat' and featured in hit global Netflix docuseries 'Pandemic: How to Prevent an Outbreak'.This discussion covers a range of topics from the perspective of true entrepreneurs. Including an impressive career history, acquisition story and the insight behind Stephanie's latest foray into writing as the author of 'Building Backwards to BioTech' - an industry-defining project.Sharing stories from inside life as successful co-founders, as well as the journey to acquisition and challenges and learnings along the way. If you're interested in becoming a brilliant biotech entrepreneur or learning about how to become acquired as one, this is the episode for you.To discuss talent solutions, or to tell your own leadership story, reach out to Jack on LinkedIn, or at jack.maclean@charltonmorris.com. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Jack speaks with Twlya Tiongson Neal, Managing Director at Accenture. This was a great discussion on commercial strategy and what this looks like in the current life science landscape, the journey into commercial consulting and optimising your business and team for commercial success.Twyla's extraordinary career history, previously heading up teams at IBM and GE Healthcare, makes for an insightful and engaging discussion on commercial growth and strategy. We discuss trends in the market, where she believes the opportunities are, leadership and problem-solving and the importance of communication, amongst other brilliant stories and takeaways.If you're interested in leadership stories, commercial growth strategies or general insights into the future for life science markets, then be sure to have a listen.To discuss talent solutions, or to tell your own leadership story, reach out to Jack on LinkedIn, or at jack.maclean@charltonmorris.com. Hosted on Acast. See acast.com/privacy for more information.

The women's health space is suffering from vast underinvestment. In this live episode, Senior Consultant in this space, Jordan Burgin, is joined by three prominent figures in the field of healthcare and medical technology to discuss 'Changing the Future for Femtech'.Keren Leshem is CEO at OCON Healthcare and a mentor at 80-400 the Health Network. She has been recognised as a World Economic Forum Tech Pioneer for 2022 amongst other impressive achievements.Barry McCann is Founder and CEO of NUA Surgical, bringing a wealth of experience in Surgical Obstetrics and innovation to the panel.Angela Dotson is COO of Alta Science Ltd., an esteemed board member and med-tech angel investor, with a background providing strategic insights to operational strategy for healthcare.Not only are these thought leaders passionate about the future of women's healthcare and its technology, but they campaign for how to overcome barriers and challenges in the industry with some invaluable points during this discussion.The diverse range of perspectives shared during this fascinating chat, including a live Q&A from the audience, is sure to highlight never-before-seen insights into the future of women's healthcare.To discuss any of the points raised in this discussion in some more detail, get in touch with Jordan on LinkedIn or drop him an email at jordan.burgin@charltonmorris.com. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Jack speaks with Synda Clements, Director of Talent Acquisition at ConcertAI. This was a great discussion about Talent Strategy and it's importance, using data to inform hiring decisions and key learnings and challenges from her years in the industry.From learning on the job in recruitment to finding her niche in Life Science, Synda has a brilliant and insightful story to tell with plenty of tips for those looking to climb the ladder in talent acquisition. Touching on key topics such as overcoming hiring shortages during economic challenges, how to use marketing in a HR role, and how to forge a path towards a leadership position to meet your goals. As well as plenty of insight into working in the world of AI.If you're interested in talent, leadership stories, or general insights into the world of biotech, then be sure to have a listen.To discuss talent solutions, or to tell your own leadership story, reach out to Jack on LinkedIn, or at jack.maclean@charltonmorris.com. Hosted on Acast. See acast.com/privacy for more information.

In this live panel discussion, industry experts Karen Todd, Doug Reader, and Zacharia Levine discuss the importance of gender equity and introducing female-first policies across the nutraceutical industry. Hosted by CM Business Consultant, Emily Austin, a specialist in the nutraceutical space.Karen Todd, CEO of Kyowa Hakka USA and Chair of the Women In Nutraceuticals (WIN) Organisation, shares insight into why gender equity and female-first policies are crucial in the industry right now, as well as identifying gaps in the market that can be addressed to achieve gender equity.Doug Reader, another board member at WIN, joins to discuss the importance of his role in the organisation and the positive change he is conscious must be driven in the industry. Doug shares lessons he has learned throughout his experience as CEO at Arizona Nutritional Supplements (ANS), emphasising the significance of gender diversity boards and their crucial impact on creating better business.Director of People & Sustainability at The Synergy Company, Zacharia Levine, joins later to share his insights on implementing policies which support gender equity and its equal importance for companies across the space - no matter their size. He provides insights into the policies that work and how different businesses can adapt and implement change.For anyone interested in changing perspectives and creating a truly diverse, equity-first and inclusive environment within their business, there are invaluable takeaways here no matter your industry. Listen now, or get in touch with Emily below to discuss this topic in some more detail.For more on talent retention strategies from the team at Charlton Morris, click here, or get in touch with Emily at emily.austin@charltonmorris.com or connect on LinkedIn to chat. Hosted on Acast. See acast.com/privacy for more information.

Corporate development refers to the planning and execution of strategies to meet organisational objectives. The process includes management of team recruitment, phasing in or out of markets or products, arranging strategic alliances, identifying, and acquiring companies (M&A), securing corporate financing, divesting of assets or divisions, and management of intellectual property.In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights.Antonio Sanchez-Cordero, a global executive with more than 15 years experience across the healthcare industry and VP of Corporate Development in speciality diagnostics at Thermo Fisher Scientific.Nick Talbot, is an experienced business development strategy lead and Vice President of Corporate Development and Strategy at BD.We covered a range of strategies to identify companies and market opportunities, including importance, alignment, consistency, vision and roadmap, criteria, working with stakeholders and corporate strategy in M&A – which can easily be overlooked.Alongside this, Nick and Antonio covered the structure to build and execute a successful deal, how to successfully integrate a company into a larger organisation during the execution phase, and share their insight in a live audience Q&A at the end of the session too.If you'd like to learn more about the panel or myself, feel free to get in touch via adam.hargreaves@lifesci-cm.com or connect with me on LinkedIn to chat.To find out more about CM Life Science, and our full range of talent solutions services, click here or drop me a message today. Hosted on Acast. See acast.com/privacy for more information.

In this episode CM Life Science Business Consultant, Owen Chandler, invites Co-Founder and Chief Lab & Innovation Officer at MySimplePetLab, Dennis Chmiel to chat all things expansion in this ever-growing market.Dennis has an in-depth career history, speaking on behalf of leading innovators in the space, he has always thrown himself into finding future innovations in animal health through harnessing technology. In this episode, Dennis tells us how his mindset fuels opportunities for growth, what he's learned along the way, and what securing Series A funding as a new player in the market means for market expansion in the sector.MySimplePetLab is a tech-enabled pet care company offering both at-home and in-clinic pet testing. It claims to take on the expert nature of effective pet testing, so the customer doesn't have to. Designed to make pet care testing and results accessible to veterinarians for vets, pets, and pet parents alike. With an aim to keep it simple for both veterinarians and pet owners through a comprehensive offering of vet-approved tests, MySimplePetLab provides the kit, technology, lab, operations, and results to deliver simple pet care for all using an effective data-driven approach.If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please drop me a message at owen.chandler@lifesci-cm.com or let's connect on LinkedIn. Hosted on Acast. See acast.com/privacy for more information.

In this episode, global medical imaging specialist Ellen Stanton catches up with Laura Piila, VP of Devices at Optomed. Following her successful "Women of the Week" LinkedIn series, Ellen was keen to invite Laura to discuss her insight into forging a career path as a woman in STEM.Optomed is a leading medical technology manufacturer of handheld fundus cameras globally. Through integration of software and Artificial Intelligence solutions, its technology enables eye screening for everyone, wherever they are, helping to detect diabetic retinopathy - a treatable disease if detected early.From fascinating insight into securing FDA approval at Optomed, to discussing the journey Laura has been on in her own career. This episode touches on the challenges she has faced and overcome as a woman in STEM, and loads more. If you're a woman making your way in the industry or are interested to hear the perspective of a leader in her field, then be sure to have a listen.Would you like to discuss this topic, or others in the market, with Ellen in some more detail? Drop her a message at Ellen.Stanton@medical-cm.com or connect with her on LinkedIn to chat. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Elissa speaks to Leigh Fell, Chief Executive Officer at Caritas Neuro Solutions, a boutique clinical stage CRO specialising in neurology and mental health. Caritas Neuro Solutions are a boutique research organisation specialising in matters of the mind - mental health, mindset, neurology and psychiatry. With experience partnering with organisations in various disciplines, Caritas has successfully brought a wealth of experienced professionals together across commercial, academic and non-profit environments. Leigh touches on a wealth of topics, including lessons learned from her years in oncology and applying these to a new CRO in the neurology market, the impact work-life balance has on managing your mindset and what this means for workplace success, and the crucial role psychedelic drug discovery can have on treating neurological disorders. Whether you're in the CRO market or are interested in hearing an engaging story from a thought leader in the mental well-being space, this one is certainly worth a listen! If you'd like to chat some more about the themes discussed in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please drop Liss a message at elissa.buxton@lifesci-cm.com or let's connect on LinkedIn.

Metasphere is ready to take their commercial plans to a new level. Play this podcast to find out more.

In this episode Ryan Gillon, CM Medical Associate Director specialising in the aesthetic health industry, speaks with Peter Prendergast, founder of the app MeTime and leading medical aesthetic doctor. Here, they discuss the current state of the aesthetics market post pandemic, and the impact that self-reflection via continuous video calls, otherwise known as the "zoom effect", has had on the industry. From his experience as a medical professional leading an award-winning clinic, to the development of one of the first aesthetic healthcare apps set to change the game for good, Peter shares a wealth of knowledge and insight from his role in the industry. Whether you're in the digital health, aesthetics, or wider medical industries, this is certainly one to tune in to. If you'd like to discuss any points featured in this episode, discover how you can become a future podcast guest or want to learn more about our CM Medical services; then please get in touch at ryan.gillon@medical-cm.com.

In this episode of CM Conversations mini-series, Lessons from Leaders in Life Science, CM Life Science Business Consultant, Jack Maclean, speaks with Kirk Sudheimer, SVP of BD & Sales at Health Catalyst. As a life science leader with a wealth of experience, and fondness, for helping emerging companies bridge the chasm from technology-led to commercially viable, Kirk was a brilliant final guest for this three-part series. His wealth of knowledge for the horizontal collaboration necessary between product, marketing, sales, and people to achieve core organisational goals sees this episode share never before heard tips and tricks for a thriving business. Health Catalyst is bringing the software, data, and services to enable providers to optimise each patient's health using the right evidence, analytics, and methods to truly transform the future of healthcare. Whether you're interested in learning valuable insight from a leader in Life Science, great tips for innovating organisations, or top tips on climbing to the top – then be sure to have a listen! If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please get in touch jack.maclean@lifesci-cm.com or let's connect on LinkedIn.

This episode of CM Conversations speaks with Dr. Callie Seaman, a formulation chemist with over 20 years experience in the hydroponics industry. Through her own struggle with epilepsy, she has become a leading advocate and educator for medicinal and prescription cannabis in the UK. Alongside her important work campaigning in this field, she is a Director at Aqualabs and MedCan Support. In this episode Business Consultant Joe Holmes, a specialist recruiter in the medical cannabis market, discusses with her the challenges, likelihood, and potential benefits of legalisation in the UK and what this really means for the industry. Whether you're in the cannabis industry or not, this episode has some invaluable insight for anyone interested in new and emerging markets in the Life Science sector. If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please drop me a message at joe.holmes@lifesci-cm.com or let's connect on LinkedIn.

In this episode of CM Conversations mini-series, Lessons from Leaders in Life Science, CM Life Science Business Consultant, Jack Maclean, speaks with Grant Neckermann, SVP of Talent at Syapse. Syapse is an innovator in the oncology space, changing the way data is used to help leading doctors and researchers make better decisions and accelerate the future of medicine. In this episode, we talk all things talent. From the passion Grant had for his own progression, to leading an innovative start-up through the challenges of ensuring impactful growth through investment in people. Whether you're interested in learning valuable insight from a leader in Life Science, great tips for talent management, or just want to hear an inspiring story – then be sure to have a listen! If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please drop me a message at jack.maclean@lifesci-cm.com or let's connect on LinkedIn.

In this episode of CM Conversations mini-series, Lessons from Leaders in Life Science, CM Life Science Business Consultant, Jack Maclean, speaks with Jen Skeen, Chief Operating Officer at Renegade.bio. Moving from a scientific background to the forefront of an innovative leadership team at a disruptive company like Renegade.bio is no mean feat. Jen delves into the trials and tribulations of her climb to the top as a woman in science, discussing how to find your niche and build a career based on what you like. Whether you're interested in learning valuable insight from a leader in Life Sciences, great tips for networking in the space, or want to hear an inspiring story – then be sure to have a listen! If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please drop me a message at jack.maclean@lifesci-cm.com or let's connect on LinkedIn.

In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, Nathan Sharpe speaks with Wendy Harman, Vice President of Product and Commercial at Weavr Health. After being selected as one of the Built In Boston 'Best Small Companies To Work For', and announcing its recent Labcorp partnership, we discuss the successes and challenges of retaining a core company culture when scaling a fast-growing start-up. From how to build a company culture that attracts the best talent, to what makes their innovative approaches and technologies different to others in the market, Wendy shares plenty of insight you won't want to miss. Whether you're in the diagnostics industry or not, this episode has some invaluable info for those looking to change an industry's approach to company culture. If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then drop Nathan a message at nathan.sharpe@lifesci-cm.com.

In this episode, I talk to Avi Fischer, CEO of innovative Italian medtech start-up, Electrophysiology Frontiers. He discussed the excitement and challenges of heading up a start-up creating a unique catheter ablation product, the first of its kind in the market. We discuss the future of cardiac ablation procedures and the innovative devices under development which are set to change the landscape of how we treat A-fib. Whether you're in the device or wider Cardiovascular market, Avi's insight as an ex-physician and successful industry leader is not one to miss! If you'd like to get in touch to discuss any points featured in this episode, would like to be a future podcast guest or want to learn more about our CM Medical services; then please email me at james.christopher@medical-cm.com.

In the final part of this three-part episode, Dennis and Adam discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the scenes at Predicine. Dennis touches on how to become a legendary company in your market, and what this means in liquid biopsy terms. A truly eye-opening discussion which anyone would be sure to gain something from. In parts one and two, we discussed the importance of liquid biopsy for the future oncology market as well as strategies for overcoming barriers when entering new markets. A huge thanks to Dennis for coming on to share his knowledge and experience. If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.

In part two of this three-part discussion, Adam and Dennis discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering the market. Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Discussing the challenges and opportunities he's faced as the CEO of Predicine in Europe. This conversation comes in three parts. In part one, the pair discussed the importance of liquid biopsy for the future oncology market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available. If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.

In the second episode of Diagnostics Digest, Adam speaks to Dennis Merkle, CEO of Europe and Global Head of Biopharma Business for molecular insights company, Predicine. Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Here we jump into a well-rounded discussion on the benefits of liquid biopsy in today's oncology market. This conversation comes in three parts. In part two, we delve into crucial barriers within the market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available. If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.

In this episode we speak with Sandeep Sandhu, General Manager of the Americas at RPM Global, about the power of digitisation to help traditional mining practices meet sustainable goals. In this discussion, our Associate Director at CM Industrial and specialist recruiter in the global Mining space, Jamie Sheard, discusses the the importance of software and cloud-based technologies as mining solutions, and the role digitisation plays in reaching sustainable goals. RPM Global is an Australian based company, whose recent expansion and success across the Americas is largely attributed to these strategies. Whether you're in the mining technology industry, are interested in ways to adapt business models to meet new sustainability initiatives or are interested in learning about expansion into new territories, there's something in here for everyone. Enjoy! Please get in touch with Jamie at jamie.sheard@industrial-cm.com, if you'd like to discuss the topic and trend in some more detail.

In this episode I talk to Bassel Rifai, SVP and Chief Marketing Officer at Ambu A/S, a company whose single-use endoscopes are some of the most innovative currently available on the market. Despite potential questions as to its sustainability, the result of COVID makes these products more crucial than ever. Bassel touches on these alongside many other interesting topics, including key learnings, challenges and successes Ambu has embraced as a result of a changing market. A hugely engaging personality with some brilliant insight into the market. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Medical services; then please email me at jordan.burgin@medical-cm.com.

This is the first in a new CM Life Science series discussing trends and insights into the diagnostics market with industry leaders from across the globe. In this episode, I talk with Delphine Galezowski, Director of Market Development in Europe for Adaptive Biotechnologies. We discuss European market expansion strategies within the diagnostics space, the differences between European market access and other global territories, and insights from her time leading teams at AstraZeneca. Whether you're in the diagnostics industry, are intrigued by market access strategies, or are wondering how different organisations and regions differ within the market – then be sure to have a listen. In the following episodes my colleagues will be discussing a range of key trends and insights into key topics within the wider diagnostics market, too. So please subscribe to the series to be notified when their episodes become available. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Life Science's services; then please email me at eleanor.doolin@lifesci-cm.com.

In this episode I speak with Laura Bishop, Director of Infinitas Design and Chair of the GSHPA. As a specialist recruiter in the Rotating Equipment Space, I was keen to discuss the noticeable lack of talent in the booming heat pump market with someone as insightful as Laura. As governments continue to implement extreme sustainability goals, is the market set to grow at an unmanageable rate? We discuss this, and much more, as she pulls on her wealth of industry experience from leading sustainable design teams at EON to launching her own commercial and industrial renewable heat systems company in October 2020. Whether you're in the heat pump market, are intrigued by discussions around the future impact of government mandates and new technologies or are wondering what their introduction means for your company and market – then be sure to have a listen. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Industrial's services; then please email me at will.brockbank@industrial-cm.com.

In this episode, I talk to Vered Caplan, Chief Executive Officer at Orgenesis Inc. Their Point Of Care (POC) Platform aims to shape a Cell and Gene Therapies (CGT) ecosystem which can lower costs for innovators, accelerate treatments to market, and expand access for patients. Together, we discuss the importance of POC platforms post-COVID-19, and the important role of these technologies to help drive forward innovation in the CGT markets. We also talk about the future of the space and exciting plans in the pipeline for Orgenesis Inc. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Life Science's services; then please email me at spencer.knight@lifesci-cm.com.

The Reality of a Smart Factory Future Part 3: How Far Are We From a Dark Warehouse? In the final part of this three-part series, our CM Industrial Business Consultant, Sameer Jaffary, chats to Marcel van Schijndel, CEO and founder of WSR Solutions. As a specialist recruiter in the Intralogistics & Warehouse Automation market, Sameer discusses what increased levels of automation really mean for the future of the industry with Marcel, who shares his insight as founder of a fully automatic mixed palletizing solutions organisation. Whether you're in the warehouse automation market, are intrigued by wider discussions around Smart Factories, or are wondering what their introduction means for the future of your company and market – then be sure to have a listen. There's plenty more industry insight in the two previous episodes, which cover the impact and introduction of 3D Printing and Industrial Automation within the Smart Factory, and how these facilitate the future Dark Warehouse. Subscribe to the series to be notified when all episodes are available. Please get in touch with Sameer at sameer.jaffary@industrial-cm.com, if you'd like to discuss the topic and trend in some more detail. To find out more about what we do at CM Industrial, click here.

The Reality of a Smart Factory Future | Part 2: Remote Monitoring to Teleoperation in the Smart Factory In part two of this three-part series, our CM Industrial Business Consultant, Alex Cawkwell, chats to Fredrik Ryden, CEO of Olis Robotics. As a specialist recruiter in the Industrial Automation market, I discuss what increased levels of automation really mean for the future of the industry with Frederik, who shares his insight as an innovator and leader in the remote handling and telemonitoring market. Whether you're in the industrial automation industry, are intrigued by discussions around Smart Factories, or are wondering what their introduction means for the future of your company and market – then be sure to have a listen. There's plenty of brilliant insight in my colleague, Ben Cheetham's previous episode, too. In the final of this mini-series, Sameer Jaffary will also be discussing the impact of Smart Factories on the industrial and warehouse automation markets, too. Subscribe to the series to be notified when all episodes are available. Please get in touch with Alex at alex.cawkwell@industrial-cm.com, if you'd like to discuss the topic and trend in some more detail. To find out more about what we do at CM Industrial, click here.

The Reality of a Smart Factory Future | Part 1: What Part Does 3D Printing Play in the Smart Factory? In part one of this three-part series, our CM Industrial Business Consultant, Ben Cheetham, chats to Mike Yang, COO of LuxCreo. As a specialist recruiter in the Additive Manufacturing market, it was great to discuss Mike's insight from the inner workings of a 3D printing and large scale manufacturing company, and what he believes its part can be in the 'Smart Factory' future. Whether you're in the additive manufacturing industry, are intrigued by discussions around Smart Factories, or are wondering what their introduction means for the future of your company and market – then be sure to have a listen. In the next episodes, my colleagues, Alex Cawkwell and Sameer Jaffary, will also be discussing the impact of Smart Factories on the industrial and warehouse automation markets, too. So please subscribe to the series to be notified when their episodes become available. Please get in touch with Ben at ben.cheetham@industrial-cm.com, if you'd like to discuss the topic and trend in some more detail. To find out more about what we do at CM Industrial, click here.

In this episode we speak with Sandeep Sandhu, General Manager of the Americas at RPM Global, about the power of digitisation to help traditional mining practices meet sustainable goals. In this discussion, our Associate Director at CM Industrial and specialist recruiter in the global Mining space, Jamie Sheard, discusses the the importance of software and cloud-based technologies as mining solutions, and the role digitisation plays in reaching sustainable goals. RPM Global is an Australian based company, whose recent expansion and success across the Americas is largely attributed to these strategies. Whether you're in the mining technology industry, are interested in ways to adapt business models to meet new sustainability initiatives or are interested in learning about expansion into new territories, there's something in here for everyone. Enjoy! Please get in touch with Jamie at jamie.sheard@industrial-cm.com, if you'd like to discuss the topic and trend in some more detail.

We talk to Tim Roberts, who's Chief Commercial Officer at PCI Pharma Services. Together, we discuss his experiences over the last 18 months and the impact that COVID-19 has had on the clinical trial supply market. We also talk about the future of the space and how companies are becoming more customer centric, among other things. The host for this episode is Ameer Khan - a global headhunter with CM Life Science. If you'd like to get in touch with Ameer about this episode, being a future podcast guest or to learn more about his services; then please email Ameer.Khan@lifesci-cm.com. For more info about CM Life Science, please visit www.searchinglifescience.com.

The hydrogen industry is going through an important transition in response to ongoing environmental and sustainability issues. In this CM Industrial Live Conversations, our Business Consultant, Andrew Jack, spoke to Sean MacKinnon, Chief Scientist at Loop Energy about recent industry news and what it really means. References: NREL/USDOE/ANL paper comparing the Toyota Mirai Fuel Cell Vehicle to a Mazda 3 ICE vehicle and the carbon intensity from feedstock can be determined from the GREET model. Energy Systems. Argonne national laboratory. The Greenhouse gases, Regulated Emission, and Energy use in Technologies Model (GREET) model. Reference 10: https://greet.es.anl.gov.

It's crucial for Medical Device and Biotech leaders to understand the intricacies of healthcare reimbursement! Only then, will your business truly benefit from it. In this live webinar, hosted by CM Medical, we went in search of expert reimbursement advice - speaking to Deborah Rizzi and Steven Haken of Odelle Technology. For more info about this topic, email us at cmconversations@charltonmorris.com. And for the full video recording, please go to www.searchingmedical.com.

This episode is all about water reuse. And to speak about this topic, we were joined by Guillaume Clairet, Chief Operating Officer & Alejandro Sturniolo, Global Head of Water Reuse & Strategic Partnerships at leading water and wastewater technology company, H2O Innovation. Together, we discuss the importance of water reuse to combat drought, as well as the impact that reuse systems have had in the areas they've been successfully implemented. We also ask Guillaume and Alejandro about how we can remove the stigma surrounding re-used water. And we discuss examples of industry leaders that are working hard to educate the public about this.

In this live webinar, hosted by CM Life Science's Lucy Smith, we discussed taking advantage of data to optimise your labs. To do this, we were joined by a panel of leaders from the digital lab solutions space including: Robert Pemberton, the CCO of Elemental Machines Erwin Seinen, the CO- Founder of ElabNext Amanda Allen, the Senior Director of Operations at Scorpion Therapeutics During the conversation, our experts talk about how data translates in the lab world, the challenges and strategies surrounding data maturity and what lab data will look like in the future. For more content like this, please visit www.searchinglifescience.com.

The water industry's talent market is going through an exciting, but challenging transformation! In CM Industrial's latest live webinar, we spoke to water industry leaders about how they're attracting, hiring and retaining top talent. Our expert panel included: Erin Rothman, CEO of StormSensor Ken Bockhurst, CEO & Chairman of Badger Meter Lukas Loeffler, Managing Partner of LLIMC LLC From the webinar, you'll find out how these industry experts are diversifying their tactics to attract, retain and hire the best talent in water industry. This event was created in partnership with The Water Council. If you'd like to be involved in future webinars like this, please get in touch. We also create podcasts, articles and videos about the industry. For more water content like this, you can also visit the webinar host, Alex Mason's profile page.

In this episode, Henry Bell discussed the future of cardiology in Latin America. He was joined by Luis Fonseca, the General Manager for Canada and Latin America at Inari Medical.

In this CM Industrial Live Conversations, Alex Mason, our Senior Consultant, spoke to Cameron Lippert, the CEO of PowerTech Water. They discussed emerging trends and changes within the water sector, as well as PowerTech Water's exciting technology and growth plans!

CM Industrial's Danial Olufunwa speaks to Joost van Helden, who's a Senior Program Manager of Digital Execution at Eni. Together they discuss the implementation process for digitalisation and how your company can go about achieving operational excellence. For more content like this, please visit www.searchingindustrial.com. And as always, if you have any questions about this episode, please email us at cmconversations@charltonmorris.com.

Improving the environmental impact of mining has long been a priority for the industry. So much so, that organisations such as FLSmidth have committed to initiatives like MissionZero - a sustainability programme to reduce emissions in cement and mining to zero by 2030. In this live CM Conversations episode, I speak to Mikko Keto, the President of the Mining Industry at FLSmidth. We discuss why his company made this commitment, the impact it's had on business, how they're progressing with this goal. For more content like this, please visit www.searchingindustrial.com.

What challenges must be overcome to ensure a successful expansion into the US medical imaging market? And what lessons have been learned by those imaging leaders that have been there and done it? To find out, CM Medical spoke to a panel of medical imaging leaders, who have enjoyed success in the US market: Ben Panter, CEO of Blackford Analysis Kyle Frye, President of SyntheticMR For more content like this and information about CM Medical as a search firm, please visit searchingmedical.com. If you have any question about the podcast or would like to be a part of a future episode, please email cmconversations@charltonmorris.com.

While CROs and healthcare have continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains a huge challenge. So, what are companies doing to improve the situation? And what practical steps will be taken to ensure more diverse clinical trials in the future? To find out, we spoke to a panel including three clinical trial experts in a live webinar: Matt Walz, CEO of Trialbee John Reites, CEO of THREAD Stuart Goldblatt, former Chief of Organisational Effectiveness at Covance and a current operational effectiveness & strategy leader. Together, we spoke about decentralised trials, telehealth, engaging rural populations and more. To receive a downloadable PDF of all the event's major takeaways, click here. This is only the beginning of addressing diversity in clinical trials and I'm aware of how important diverse voices are. So, CM Life Science will continue to provide podcasts, articles and webinars on this. If you'd like to get involved or know anyone who would – please get in touch. Our email is cmconversations@charltonmorris.com For more about Elisabeth, your host for this podcast, please visit her profile page.

How do we convince the world that waste management is smart? And how do we get the public to engage with its new, smart systems and technology? In this podcast (which was hosted as a live webinar), we asked those big questions to two global leaders in smart waste technology: Georg Bassenge, Director of Europe at Ecube Labs & Head of Business Development at emz - environmental technology GmbH Theo Kik, Managing Director at Mr. Fill & Smart City Lease B.V. From the podcast, you'll find out how these industry experts are changing perceptions about waste management processes, how they're convincing municipalities & governments to invest in our industry and how they're getting the general public to engage with their technology! For more content like this, visit searchingindustrial.com. And if you'd like to join us on a podcast or webinar, please get in touch by emailing cmconversations@charltonmorris.com.

The talent shortage in the construction industry is nothing new; it's a problem that has burdened the sector for a number of years. With the Data Centre, Life Science and Healthcare markets all seeing a huge rise in activity over the last 18 months, the talent gap is starting to severely affect these hi-tech construction markets. Construction companies are fighting for the best talent and many are struggling to find the right people. So how do we solve this issue? Gratefully, Modubuild's Talent Experience Specialist Ciara O'Dwyer was at hand to give the inside scoop on how internal talent specialists are tackling this challenge and whether modular construction can truly bridge the talent gap in our industry.Modular construction is seen by many as the future of the industry and requires new skillsets that previously weren't as vital within the construction process. This is opening up new possibilities for people to enter the construction industry, who may not have previously considered the sector as a career option.If you have any questions about the podcast, please don't hesitate to email me at Henry.Longhurst@industrial-cm.com. And for more of my content, please click here. For more about CM Industrial and what we do as a search firm, click here.

Starting a new role is daunting at the best of times. But starting a role remotely in a leadership role in a pandemic is a whole new challenge. But that's exactly what Thierry Faye had to do when he started his role as Senior Marketing Director with Markes and SepSolve this year. In this episode of CM Conversations, Thierry shares his tips on hitting the ground running and building a team without meeting them, as well as the importance of investing in relationships. In his words, you should always be visible and always be available. If you're starting a new role or planning to hire yourself, this episode has some fantastic tips for you to take away. For more great content from the Life Science space, visit www.searchinglifescience.com

In this episode of CM Conversations, we talk to Peter Chang - who's Co-Director at the UCI Center for AI in Diagnostic Medicine, as well as the Co-Founder & CEO of Avicenna.ai. In our discussion with Peter, we talk about AI in medical imaging and how this market has become so saturated over recent years. In this podcast, Peter also offers advice on how companies can improve their offering and future-proof their business to really stand out in the medical imaging marketplace. Whether you're from a commercial, technical or medical background; I think there is something valuable here for everyone to takeaway. For more content like this, please go to www.searchingmedical.com

Lateral flow tests have been crucial in the global response to the COVID-19 pandemic and will be a major part of the world's return to normality. In this live webinar, we asked three experienced commercial leaders about their insights, advice and predictions on the future of this market. Our panel included: Leigh Thomas - Senior VP, Director of Global Sales at Abingdon Health Angus Urquhart - Sales Director at Katalyst Laboratories Robert Miller - President of Drummond Scientific To get in touch with the host of this event, Nathan Sharpe, please give him an email at Nathan.Sharpe@lifesci-cm.com. If you'd like to collaborate with CM Life Science on future content or learn about our offering as a search partner, go to www.searchinglifescience.com.

3D Printing has had a major impact on global supply chains, with the technology allowing manufacturers to print small runs of products from a wide variety of materials. This type of manufacturing requires less physical stock, creates less waste and doesn't require mass shipping – which is much better for the environment. While we have begun to take advantage of these benefits – and many others – we know we can do more to truly harness the full potential of 3D printing and further embrace localised manufacturing. To find out how, we spoke to Gregor Reischle who's Global Head of Industrial Additive Manufacturing and Program Manager Supply Chain Intelligence at TÜV SÜD – a company that's work hard to build trust in localised manufacturing with its comprehensive portfolio of testing, certification, auditing and advisory services. For more information about CM Industrial and the work we do in this market as a global search firm, go to www.searchingindustrial.com.

In this episode, CM Life Science's Adam Hargreaves catches up with Miron Tokarski, CEO of Genomteca company operating in the field of clinical diagnostics. Also joining them was Magdalena Kicińska, Marketing Partner at Genomtec. During the conversation with Miron, Magdalena and Adam they discussed the innovative work being done by Genomtec, the market landscape as a whole and how they're standing out in the wider space. For more content about the Life Science industry, please visit searchinglifescience.com and if you have any feedback about this episode we'd love to hear it. Please email cmconversations@charltonmorris.com.